Jinling Pharmaceutical Co Ltd banner
J

Jinling Pharmaceutical Co Ltd
SZSE:000919

Watchlist Manager
Jinling Pharmaceutical Co Ltd
SZSE:000919
Watchlist
Price: 7.88 CNY -1.01% Market Closed
Market Cap: ¥4.9B

Jinling Pharmaceutical Co Ltd
Investor Relations

Jinling Pharmaceutical Co. Ltd. engages in the manufacture and sale of pharmaceutical products. The company is headquartered in Nanjing, Jiangsu and currently employs 4,865 full-time employees. The Company’s main products include Mailuoning injections, ferrous succinate tablets and Lentinan injection, among others. The firm is also involved in the provision of medical services and the sale of medical instrument. The firm distributes its products in domestic market, with North China as its main market.

Show more
Loading
000919
Shanghai Composite
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Yang Wang
VP, Chief Accountant & Non-Independent Director
No Bio Available
Mr. Quan Li
Chief Economist
No Bio Available
Ms. Mingyi Jia
Chief Engineer
No Bio Available
Mr. Jian Wang
VP & Non-Independent Director
No Bio Available
Mr. Jun Yang Xu
Secretary
No Bio Available
Mr. Xinning Zhu
Assistant to President
No Bio Available
Mr. Zhenxin Xi
General Manager Assistant
No Bio Available
Mr. Wei Guo Tang
Executive Vice President
No Bio Available

Contacts

Address
JIANGSU
Nanjing
Jinling Medicine Mansion, No.238 Zhongyang Road
Contacts
+862583118511
www.jlyy1999.com
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett